Total Payments
$953,600
2024 Payments
$395,742
Companies
28
Transactions
1,516
Medicare Patients
12,646
Medicare Billing
$1.7M
Payment Breakdown by Category
Consulting$531,944 (55.8%)
Other$365,218 (38.3%)
Food & Beverage$31,437 (3.3%)
Travel$24,958 (2.6%)
Education$42.86 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $531,944 | 208 | 55.8% |
| Acquisitions | $307,644 | 1 | 32.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $55,074 | 28 | 5.8% |
| Food and Beverage | $31,437 | 1,199 | 3.3% |
| Travel and Lodging | $24,958 | 76 | 2.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,500 | 1 | 0.3% |
| Education | $42.86 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Haemonetics Corporation | $330,443 | 3 | $0 (2024) |
| Medical Device Business Services, Inc. | $289,844 | 175 | $0 (2024) |
| Biosense Webster, Inc. | $223,006 | 365 | $0 (2024) |
| Abbott Laboratories | $40,947 | 353 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $30,125 | 132 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $26,325 | 31 | $0 (2024) |
| Medtronic, Inc. | $3,224 | 81 | $0 (2024) |
| ATRICURE, INC. | $2,226 | 27 | $0 (2024) |
| PFIZER INC. | $1,922 | 163 | $0 (2024) |
| Boston Scientific Corporation | $1,303 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $395,742 | 148 | Haemonetics Corporation ($330,443) |
| 2023 | $87,217 | 246 | Medical Device Business Services, Inc. ($66,750) |
| 2022 | $103,078 | 200 | Medical Device Business Services, Inc. ($88,027) |
| 2021 | $67,583 | 156 | Medical Device Business Services, Inc. ($35,375) |
| 2020 | $110,625 | 140 | Biosense Webster, Inc. ($63,266) |
| 2019 | $89,352 | 200 | Biosense Webster, Inc. ($58,959) |
| 2018 | $50,565 | 244 | Biosense Webster, Inc. ($29,776) |
| 2017 | $49,437 | 182 | Biosense Webster, Inc. ($20,935) |
All Payment Transactions
1,516 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $26.87 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/17/2024 | Medical Device Business Services, Inc. | CARTO 3 (Device) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/17/2024 | Becton, Dickinson and Company | HemoSphere (Device) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Hemodynamic Monitoring | ||||||
| 12/09/2024 | Biosense Webster, Inc. | NUVISION ICE CATHETER (Device), QDOT MICRO Catheter | Food and Beverage | In-kind items and services | $148.37 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2024 | Abbott Laboratories | ENSITE PRECISION (Device) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Electrophysiology | ||||||
| 11/21/2024 | Medtronic, Inc. | EVERA MRI XT DR SURESCAN (Device) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Medical Device Business Services, Inc. | CARTO 3 (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | CARDIVA MEDICAL, INC. | ENSOETM (Device) | Food and Beverage | In-kind items and services | $211.18 | General |
| Category: DEVICES | ||||||
| 11/06/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Medical Device Business Services, Inc. | CARTO 3 (Device) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Cardiology | ||||||
| 10/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/18/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: DEVICES | ||||||
| 10/17/2024 | Medical Device Business Services, Inc. | CARTO 3 (Device) | Consulting Fee | Cash or cash equivalent | $5,750.00 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2024 | Medical Device Business Services, Inc. | CARTO 3 (Device) | Travel and Lodging | In-kind items and services | $143.06 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Pacemakers | ||||||
| 09/19/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Pacemakers | ||||||
| 09/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.47 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 3,210 | 5,140 | $1.8M | $431,281 |
| 2022 | 40 | 3,182 | 5,163 | $1.7M | $428,337 |
| 2021 | 38 | 3,071 | 4,436 | $1.8M | $450,310 |
| 2020 | 39 | 3,183 | 4,260 | $1.6M | $401,395 |
Total Patients
12,646
Total Services
18,999
Medicare Billing
$1.7M
Procedure Codes
159
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 106 | 107 | $350,995 | $77,568 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 411 | 587 | $130,638 | $55,928 | 42.8% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 55 | 56 | $137,592 | $36,598 | 26.6% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 98 | 144 | $176,976 | $34,252 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 171 | 171 | $59,880 | $20,782 | 34.7% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 75 | 80 | $98,400 | $18,982 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 196 | 216 | $31,688 | $14,404 | 45.5% |
| 93622 | Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | Facility | 2023 | 99 | 99 | $58,905 | $13,072 | 22.2% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 34 | 34 | $57,766 | $12,489 | 21.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 234 | 683 | $66,934 | $11,757 | 17.6% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 15 | 15 | $44,145 | $10,833 | 24.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 581 | 952 | $55,619 | $10,568 | 19.0% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 19 | 19 | $47,861 | $9,978 | 20.8% |
| 93623 | Programming of heart rhythm stimulation after drug infusion | Facility | 2023 | 141 | 146 | $85,190 | $9,699 | 11.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 103 | 321 | $66,447 | $8,316 | 12.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 93 | 140 | $24,784 | $7,984 | 32.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 134 | 365 | $38,690 | $7,890 | 20.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 59 | $18,417 | $7,456 | 40.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 88 | 97 | $14,744 | $7,049 | 47.8% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 18 | 18 | $26,681 | $6,519 | 24.4% |
| 93650 | Destruction of heart conduction tissue to create heart block | Facility | 2023 | 12 | 13 | $24,713 | $5,924 | 24.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 22 | 172 | $24,768 | $4,815 | 19.4% |
| 93462 | Insertion of tube in left heart chamber through heart septum | Facility | 2023 | 26 | 27 | $16,902 | $4,382 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $10,015 | $3,708 | 37.0% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 31 | 47 | $13,184 | $3,584 | 27.2% |
About Dr. Jason Zagrodzky, M.D
Dr. Jason Zagrodzky, M.D is a Cardiovascular Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912982018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Zagrodzky, M.D has received a total of $953,600 in payments from pharmaceutical and medical device companies, with $395,742 received in 2024. These payments were reported across 1,516 transactions from 28 companies. The most common payment nature is "Consulting Fee" ($531,944).
As a Medicare-enrolled provider, Zagrodzky has provided services to 12,646 Medicare beneficiaries, totaling 18,999 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Austin, TX
- Active Since 12/12/2005
- Last Updated 06/22/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1912982018
Products in Payments
- CARTO 3 (Device) $230,222
- Carto 3 System (Device) $221,260
- Carto 3 (Device) $51,107
- XARELTO (Drug) $30,125
- MULTAQ (Drug) $26,325
- Cardiac Mapping System (Device) $11,202
- Perclose ProGlide suture mediated closure system (Device) $9,701
- Omnilink Elite vascular stent system (Device) $6,200
- CRT-Ps (Device) $3,590
- PERCLOSE PROGLIDE (Device) $3,438
- ELIQUIS (Drug) $2,561
- ARCTIC FRONT ADVANCE (Device) $2,447
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $1,759
- Ensite Cardiac Mapping System (Device) $1,714
- Carto Smarttouch (Device) $1,584
- OCTARAY MAPPING CATHETER (Device) $1,336
- WATCHMAN (Device) $994.06
- QDOT MICRO Catheter (Device) $898.82
- Barostim Neo System (Device) $877.32
- ASSURITY (Device) $637.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Austin
Dr. Andrea Natale, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M
Dr. Rodney Horton, M.d, M.D
Cardiovascular Disease — Payments: $720,616
Cardiovascular Disease $720,616
Francis Zidar, Md, MD
Cardiovascular Disease — Payments: $448,847
Cardiovascular Disease $448,847
Vivek Goswami, Md, MD
Cardiovascular Disease — Payments: $338,027
Cardiovascular Disease $338,027
Dr. Robert Canby, M.d, M.D
Cardiovascular Disease — Payments: $225,010
Cardiovascular Disease $225,010
Jerome Thomas, Md, MD
Cardiovascular Disease — Payments: $163,563
Cardiovascular Disease $163,563